Syneos Health (Nasdaq:SYNH), the only fully integrated
biopharmaceutical solutions organization, today announced new top
talent joining the Company’s Communications business. Designed to
deliver insights-driven integrated communications, the
healthcare-only agency portfolio spans advertising, public
relations, medical communications, managed markets, omnichannel,
digital, naming, and branding. Syneos Health Communications
consistently appears on top agency ranking lists and recently
earned a top-three spot on Medical Marketing & Media’s 2020
Agency 100 list.
Purpose built to be a healthcare company delivering exceptional
communications, as opposed to a communications company doing
healthcare, the Syneos Health Communications business offers
unsurpassed breadth, scale, and the ability to go deep into a
community or disease space to translate insights into
impact.
Tim Pantello has taken the helm to lead the integrated portfolio
business, serving as President of Communications. A versatile
executive with nearly 25 years of experience across strategy,
marketing, and technology, his digitally native leadership style is
ideal for grooming the next generation of communications experts.
Prior to Syneos Health, Pantello was a managing director at
PricewaterhouseCoopers (PwC), leading multiple offerings within the
Health Industry Advisory Group related to wearable data, patient
intelligence and predictive behaviors and analytics. He reports to
Michelle Keefe, President, Syneos Health Commercial Solutions.
“Tim is further embedding strategic insights, behavioral
science, and digital transformation across our communications
business – strengthening foundational capabilities that are proving
mission critical to our customers during this transformative time,”
said Keefe. “Now more than ever, customers are relying on strategic
communications to navigate unchartered challenges. Tim’s expertise,
combining consulting methodologies and pioneering communications
practices, is getting our customers faster to what matters.”
Since joining in January, Pantello has focused on infusing data,
behavioral science, and omnichannel experiences to enhance customer
value. Bolstering senior leadership, which includes Syneos Health
veterans Sonja Foster-Storch and Lisa Stockman, Pantello has added
the following talent:
JD Cassidy, President of
Advertising Cassidy is leading Syneos Health
Communications’ North America advertising portfolio, with dedicated
responsibility for GSW NY. He joins from Saatchi & Saatchi
Wellness, where he served as President, simultaneously growing
revenue and employee engagement. He has worked on multiple brands
and therapeutic categories and has omnichannel expertise across
patients, providers, and payers. Prior to Saatchi & Saatchi, he
was in global leadership roles for Publicis Health, D.i.D, and
Digitas Health.
Maria Tender, Head of Strategy Tender is
leading strategy and planning for Syneos Health Communications. She
joins from DDB where, for more than two decades, she led strategy
and planning and built the healthcare strategy group. At DDB, she
oversaw new business development across a range of sectors,
including large pharmaceutical companies across numerous
therapeutic areas. Internally, she developed best-in-class
training and development.
Ian Dorrian, President of EU Communications
Dorrian is leading Communications in Europe and brings more than 20
years of agency experience spanning independent firms, major
holding companies, including Omnicom, regional and global roles,
and has deep therapeutic expertise in oncology and rare disease.
Prior to his agency experience, he was in the pharmaceutical
industry for 10 years, gaining experience in medical affairs, field
sales, and operational and strategic marketing roles.
“Our entire model is about acceleration and our Communications
organization is built on agility and speed. Beyond big creative and
standalone strategy, scale, clinical and scientific depth, skill
and a pure-play focus on health matters,” said Pantello in the
Medical Marketing & Media Agency 100 profile. “Our ability to
bring multiple disciplines together across the product lifecycle –
truly understanding clinical development and pulling it through
communications strategies – is unique within the industry.”
The portfolio of communications agencies at Syneos Health
includes GSW, Navicor, Chandler Chicco Agency, Biosector 2,
Chamberlain Healthcare Communications, Cadent Medical
Communications, Managed Markets Communications and Addison Whitney,
among others. Unique cross-functional teams – like Syneos Health
Value & Access – provide customers access to broad Commercial
expertise and Clinical development insights.
Syneos Health agencies work in scalable, purpose-built teams
that partner across disciplines and geographies to accelerate brand
performance.
About Syneos HealthSyneos Health (Nasdaq:SYNH)
is the only fully integrated biopharmaceutical solutions
organization. Our Company, including a Contract Research
Organization (CRO) and Contract Commercial Organization (CCO), is
purpose-built to accelerate customer performance to address modern
market realities. Our Company bring together approximately 24,000
clinical and commercial minds with the ability to support customers
in more than 110 countries. Together we share insights, use the
latest technologies and apply advanced business practices to speed
our customers’ delivery of important therapies to patients. To
learn more about how we are shortening the distance from lab to
life®, visit syneoshealth.com.
Syneos Health Investor Relations Contact: |
Syneos Health Press/Media Contact: |
Ronnie Speight |
Danielle DeForge |
Senior Vice President, Investor Relations |
Executive Director, External Communications |
+1 919 745 2745 |
+1 202 210 5992 |
investor.relations@syneoshealth.com |
danielle.deforge@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024